Sanaty IPS Launches Comprehensive COVID-19 Testing Program in Colombia
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, Sept. 11, 2020 (GLOBE NEWSWIRE) […]
Pinduoduo CEO on What’s Next for Chinese E-commerce in the Wake of the Coronavirus Pandemic
Coming on the heels of a global pandemic, newly appointed Pinduoduo CEO Chen Lei discusses how the e-commerce platform plans […]
Ascendis Pharma A/S Announces Participation at the 18th Annual Morgan Stanley Virtual Global Healthcare Conference
COPENHAGEN, Denmark, Sept. 11, 2020 (GLOBE NEWSWIRE) — Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative […]
Brown & Brown, Inc. Announces the Asset Acquisition of Frank E. Neal & Co., Inc.
DAYTONA BEACH, Fla., Sept. 11, 2020 (GLOBE NEWSWIRE) — J. Scott Penny, Chief Acquisitions Officer of Brown & Brown, Inc. […]
NexTech Now Approved Microsoft Partner
VANCOUVER, British Columbia, Sept. 11, 2020 (GLOBE NEWSWIRE) — NexTech AR Solutions (NexTech) (OTCQB: NEXCF) (CSE: NTAR) (FSE: N29), an […]
Akoustis to Present at the Lake Street Best Ideas (Big4) Growth Conference on September 17, 2020
Charlotte, N.C., Sept. 11, 2020 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) […]
Editas Medicine Announces U.S. Patent and Trademark Office Grants the Broad Institute Priority Benefit in CRISPR Interference
CAMBRIDGE, Mass., Sept. 11, 2020 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, announced today […]
CareDx Shares Latest Clinical Data at the TTS 2020 Virtual Conference
SOUTH SAN FRANCISCO, Calif., Sept. 11, 2020 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on […]
Acasti Announces Filing and Mailing of Information Circular and Change in Record Date
LAVAL, Québec, Sept. 11, 2020 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST) […]
Zentalis Pharmaceuticals to Host a Key Opinion Leader Virtual Meeting to Discuss its Investigational WEE1 Inhibitor ZN-c3 and its Potential as a Best-in-Class Treatment for Advanced Solid Tumors
NEW YORK and SAN DIEGO, Sept. 11, 2020 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company […]
